New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For MDT;CRDC;GE;SYK;AET From The Last 14 Days
Check below for free stories on MDT;CRDC;GE;SYK;AET the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
April 24, 2014
16:12 EDTGEGE investing unit exceeds $10B renewable energy milestone
Subscribe for More Information
12:50 EDTAETOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday following reports from some of the biggest names in technology and ahead of reports tonight from several other tech giants. The averages opened in positive territory, with the tech-heavy Nasdaq up more than 1% soon after the opening bell. The index was unable to hold its early gains and moved into negative territory, taking the other major averages with it. The indexes were able to keep their losses to a minimum and eventually regrouped and made it back onto positive ground, where they stood near noon. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 24K from the prior week to 329K in the week ended April 19, which was above the 315K consensus forecast of analysts, though there may have been some impact from Easter as the Bureau of Labor Statistics noted difficulty adjusting the data around the holiday. Durable goods orders rose 2.6% in March, beating the 2.0% increase that was forecast. Outside the U.S., Russia said it launched military exercises along the Ukrainian border after Ukrainian forces killed pro-Russian militants. COMPANY NEWS: Shares of Apple (AAPL) advanced more than 8% after the company reported significantly better than expected quarterly earnings and sales, particularly sales of its iPhone. Apple also announced a 7-for-1 stock split that will take effect in June, along with an 8% increase in its quarterly dividend and a $30B increase in its share repurchase authorization. Following last night's report, CLSA upgraded its rating on Apple shares to Buy from Outperform and raised its price target for the stock to $695 from $610, while Jefferies recommended "aggressively" buying shares following the Q2 results and outlook for Q3... Another tech giant, Facebook (FB), also reported earning and revenue that topped expectations last night, sending its shares higher in after-hours trading and prompting a number of price target hikes among Street analysts. However, Facebook also announced that its CFO David Ebersman will step down, to be succeeded by David Wehner, who is currently the company's Vice President of Corporate Finance and Business Planning. The social network operator traded on both sides of the flat-line this morning, but was up a bit over 1% at midday... Shares of General Motors (GM) fell about 2% after the company reported profits that narrowly edged out expectations but revenues that fell short of expectations. GM said its core operating performance has been on plan for the year CEO Mary Barra said the company has seen "no meaningful slowdown" in its U.S. sales despite the negative publicity related to its ongoing ignition switch recall and associated legal matters. MAJOR MOVERS: Among the notable gainers was orthopedic device maker Zimmer Holdings (ZMH), which climbed 11% after it agreed to merge with privately held Biomet in a cash and stock transaction valued at about $13.35B, including the assumption of net debt. Also higher following their earnings reports were Citrix Systems (CTXS), which rose 10%, D.R. Horton (DHI), which gained more than 7%, and Aetna (AET), which advanced 6%. Among the noteworthy losers was chip making giant Qualcomm (QCOM), which slid 3.5% despite reporting profits that beat expectations and raising its yearly EPS outlook, as the company also disclosed the receipt of a notice from the SEC about a potential filing of an enforcement action against the company related to anti-bribery violations. Also lower following their earnings reports were Xilinx (XLNX), which fell about 9%, Raytheon (RTN), which dropped 4%, and Hershey (HSY), which also declined about 4%. INDEXES: Near midday, the Dow was up 19.49, or 0.12%, to 16,521.14, the Nasdaq was up 25.91, or 0.63%, to 4,152.87, and the S&P 500 was up 5.35, or 0.29%, to 1,880.74.
12:10 EDTSYKZimmer advances after agreeing to merge with competitor
Subscribe for More Information
11:31 EDTAETAetna rises after topping expectations, raising guidance
Shares of healthcare insurer Aetna (AET) are advancing after its first quarter results topped analysts' consensus estimates and it raised its fiscal 2014 outlook. WHAT'S NEW: This morning, Aetna reported Q1 adjusted earnings per share of $1.98 and revenue of $13.99B, topping expectations of $1.56 and $13.72B, respectively. Medical membership in Q1 increased to over 22.7M, a sequential increase of 529,000 members. Aetna is targeting year-end medical membership of more than 23M, an increase of 800,000-1M members for the year. ďAetna posted higher operating earnings, operating revenues and medical membership in the first quarter, each representing historic highs for our company...This performance is once again a testament to the strength of our diversified portfolio, continued progress in integrating the Coventry acquisition, pricing discipline and solid execution. Our strong membership growth in the quarter came from both our commercial and government businesses, and we project this momentum will continue,Ē said Mark Bertolini, Aetna chairman, CEO and president. WHAT'S NOTABLE: The company raised its FY14 EPS view to $6.35-$6.55 from at least $6.25, versus consensus of $6.38. It also raised its FY14 revenue outlook to $56B-$57B from at least $54B, compared to consensus of $54.89B. PRICE ACTION: In late morning trading, Aetna rose $3.61, or 5.2%, to $72.52 on heavy trading volume. Including today's advance, the stock up about 27% over the past twelve months. OTHERS TO WATCH: Other companies in the healthcare benefits space include UnitedHealth Group (UNH), Cigna (CI), WellPoint (WLP) and Humana (HUM), all of which are higher on the session.
08:59 EDTAETOn The Fly: Pre-Market Movers
Subscribe for More Information
08:43 EDTSYKZimmer deal could pressure Stryker, Smith & Nephew to grow, says Wells Fargo
Subscribe for More Information
08:42 EDTGEGE reportedly only interested in Alstom's energy assets
French daily newspaper Le Figaro reports that General Electric is only interested in Alstom's energy assets, not the company's transport assets, according to Bloomberg.
07:57 EDTGEGE optimistic about return to Japanese wind market, Nikkei says
Subscribe for More Information
06:34 EDTAETAetna reports Q1 Health Care revenue $13.2B
Subscribe for More Information
06:33 EDTAETAetna sees FY14-end membership of at least 23M
06:33 EDTAETAetna raises FY14revenue to $56B-$57B from at least $54B, consensus $54.89B
Subscribe for More Information
06:14 EDTGEAlstom says 'not aware' of any potential bid by General Electric, WSJ reports
In response to a Bloomberg report that said General Electric is in talks to buy Alstom, the French train and power plant builder said it is "not aware" of any potential bid, the Wall Street Journal reports. "In response to recent speculation in the economic press, Alstom is not informed of any potential public tender offer for the shares of the company," Alstom said. Reference Link
06:03 EDTAETAetna raises FY14 EPS to $6.35-$6.55 from at least $6.25, consensus $6.38
06:03 EDTAETAetna reports medical membership totaled over 22.7M at March 31
Subscribe for More Information
06:02 EDTAETAetna reports Q1 adjusted EPS $1.98, consensus $1.56
Subscribe for More Information
April 23, 2014
17:35 EDTGEGeneral Electric in talks to buy Alstom, Bloomberg says
Subscribe for More Information
16:03 EDTSYKStryker backs FY14 adjusted EPS view $4.75-$4.90, consensus $4.84
Subscribe for More Information
16:02 EDTSYKStryker reports Q1 adjusted EPS $1.06, consensus $1.08
Subscribe for More Information
15:41 EDTSYKNotable companies reporting after market close
Subscribe for More Information
15:35 EDTAETNotable companies reporting before tomorrow's open
Subscribe for More Information
14:36 EDTAETEarnings Preview: Aetna shares relatively flat since last earnings report
Aetna (AET) is scheduled to report first quarter earnings before the market open on Thursday, April 24 with a conference call scheduled for 8:30 am ET. Aetna operates as a diversified health care benefits company in the United States. EXPECTATIONS: Analysts are looking for earnings per share of $1.56 on revenue of $13.72B, according to First Call. The consensus range for EPS is $1.44-$1.63 on revenue of $13.31B-$14.28B. LAST QUARTER:On February 6, Aetna reported fourth quarter EPS of $1.34 against estimates of $1.36 on revenue of $13.1B against estimates of $13.14B. In its Q4 report, Aetna said it sees medical membership rising by 50,000 at end of Q1. On April 17, Aetna and other health insurers fell after UnitedHealth (UNH) reported lower than expected Q1 revenue and cited taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on results. STREET RESEARCH: On March 25, FBR Capital removed Aetna from its Top Picks List due to share performance. PRICE ACTION: Shares of Aetna are up approximately 1.5% to $68.99 since its last earnings report. Shares are fractionally higher today in afternoon trading.
08:30 EDTGEPDF Solutions sell-off creates long-term opportunity, says DA Davidson
Subscribe for More Information
08:06 EDTGEGE Capital leads $135M in credit facilities for King's Hawaiian
Subscribe for More Information
07:00 EDTAETTerrapinn to hold a conference
Subscribe for More Information
April 22, 2014
10:04 EDTMDTMedtronic announces first U.S. implant of Evera MRI SureScan
Subscribe for More Information
07:25 EDTGENatural E Creative Group to hold a summit
Subscribe for More Information
April 21, 2014
18:47 EDTMDTInjunction delay 'temporary victory' for Medtronic, says Wells Fargo
Subscribe for More Information
18:20 EDTMDTEdwards Lifesciences comments on U.S. Appeals Court order
Edwards Lifesciences (EW) announced that the U.S. Court of Appeals for the Federal Circuit issued a stay for the preliminary injunction that was ordered on April 11 to limit the sale of Medtronic's (MDT) CoreValve system in the United States. According to the court's two-to-one decision, the injunction has been placed on hold "pending further notice." "We have always made every effort to ensure patients receive the treatment they need and will continue to seek a durable solution that benefits physicians and their patients. We're proud of the track record and large amount of clinical data supporting the performance of the SAPIEN family of valves, making them the preferred choice for doctors treating their patients around the world," said Michael A. Mussallem, Edwards' chairman and CEO. The order postpones the implementation of the preliminary injunction. It does not reverse the federal jury's finding of Medtronic's willful infringement, for which all appeals have been exhausted, and does not affect the determination of additional damages.
16:40 EDTMDTMedtronic confirms stay in case with Edwards regarding CoreValve granted
Subscribe for More Information
15:55 EDTMDTMedtronic motion for stay in case with Edwards granted, Bloomberg reports
Subscribe for More Information
15:42 EDTMDTLeerink's medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy discusses the litigation landscape and the next steps and potential outcomes for Edwards Lifesciences and Medtronic on an Analyst/Industry conference call to be held on April 23 at 2 pm.
09:09 EDTMDTMedtronic reports court to expedite appeal in Edwards Lifesciences case
Subscribe for More Information
08:04 EDTGEGE unit is agent on $66M credit facility for Gold Star Foods acquisition
Subscribe for More Information
07:21 EDTMDTFDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews including MDT's Activa Dystonia Therapy, (BAX's Advate and Tisseel, NVS' Famvir, Tibotec's (JNJ subsidiary) Intelence, UCB Pharma's Keppra, MRK's Maxalt, BAYRY's Natazia, Digestive Care's Pertzye, JNJ's Prezista, BMY's Reyataz, SNY's Sklice, PFE's Torisel, Aptalis' Ultresa, and GILD's Viread in a meeting being held in Bethesda, Maryland on April 21 at 8 am. Webcast Link
April 17, 2014
12:53 EDTAET, GEOn The Fly: Midday Wrap
Subscribe for More Information
10:51 EDTAETHealth insurers slide after UnitedHealth results, cautious comments
Shares of a number of health insurers are falling after the largest company in the sector, UnitedHealth (UNH), reported slightly higher than expected first quarter profit but lower than expected revenue. WHAT'S NEW: UnitedHealth's first quarter earnings per share came in at $1.10, versus the consensus outlook of $1.09. The insurer reported revenue of $31.71B, compared with the consensus outlook of $31.99B. Taxes levied by the Affordable Care Act and weak funding of Medicare Advantage by the government weighed on UnitedHealth's earnings, the company stated. Also pushing down the company's earnings was "a very expensive," new Hepatitis C therapy, UnitedHealth stated on its earnings conference call. Hepatitis C treatments cost UnitedHealth hundreds of millions of dollars in the first quarter, the company stated, though it also noted that demand for the treatments should drop going forward as initial pent-up demand for them starts to decline. The company indicated that it was looking to be reimbursed by states for the money it is spending on hepatitis vaccines for Medicaid patients. Meanwhile, UnitedHealth reiterated its fiscal 2014 EPS guidance of $5.40-$5.60 and its fiscal 2014 revenue guidance of $128B-$129B. PRICE ACTION: In mid-morning trading, UnitedHealth sank 3.7% to $75.31. Other health insurers also declined, with WellPoint (WLP) dropping 4% to $91.89, Aetna (AET) falling 3.3% to $67.54, Humana (HUM) declining 2.25% to $106.35, and Health Net (HNT) sliding 1% to $31.74.
09:07 EDTGEGE Capital says sees Q2 run rate of about $1.8B of earnings
09:05 EDTGEGeneral Electric says saw some improvement in credit demand in Q1
Subscribe for More Information
08:17 EDTGEGeneral Electric says focusing on bolt-on acquisitions
Says on track to reduce share count in 2014 and planning for 9-9.5B by 2015. Says continuing to grow dividends in line with earnings. Says M&A focused on building out core: Focusing on bolt-on acquisitions, active on divestiture front, go above $1B-$4B range only for "exceptional" value and immediate accretion. Says oil and gas industry fundamentals remain strong. Says U.S. short-cycle markets strengthened in March, appears that weather impact a "one-time" event. Says had a few "rough spots" in Q1: U.S. Healthcare and Transportation/mining. Comments from slides that will be presented on the Q1 earnings conference call.
06:35 EDTGEGeneral Electric on track to achieve goal of $1B in structural cost-out for year
Subscribe for More Information
06:35 EDTGEGeneral Electric reports Q1 GE Capital revenue $10.52B
Subscribe for More Information
06:32 EDTGEGeneral Electric reports Q1 adjusted EPS 33c, consensus 32c
Reports Q1 revenue $34.18B, consensus $34.36B
April 16, 2014
17:53 EDTMDTEdwards says not looking for complete ban of Medtronic valve, Bloomberg says
Subscribe for More Information
15:17 EDTGENotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include General Electric (GE), consensus 32c; Philip Morris (PM), consensus $1.16; Schlumberger (SLB), consensus $1.20; PepsiCo (PEP), consensus 75c; Union Pacific (UNP), consensus $2.37; UnitedHealth (UNH), consensus $1.09; Honeywell (HON), consensus $1.26; Goldman Sachs (GS), consensus $3.44; du Pont (DD), consensus $1.59; Morgan Stanley (MS), consensus 60c; Danaher (DHR), consensus 80c; BlackRock (BLK), consensus $4.14; Blackstone (BX), consensus 55c; Chipotle Mexican Grill (CMG), consensus $2.86; Mattel (MAT), consensus 9c; Snap-on (SNA), consensus $1.54; AutoNation (AN), consensus 74c.
14:13 EDTGEGeneral Electric April 26 straddle priced for 2.5% move into Q1
12:22 EDTGEEarnings Preview: Analyst sentiment mixed ahead of GE's Q1 report
Subscribe for More Information
10:08 EDTAETUnitedHealth retreats after Citi cuts rating on shares
Subscribe for More Information
09:28 EDTCRDCOn The Fly: Pre-market Movers
Subscribe for More Information
09:03 EDTGEGE Digital Energy providing series compensation capabilities for Scottish Power
Subscribe for More Information
08:08 EDTCRDCCardica sells 32.5M common shares at 85c
Subscribe for More Information
07:13 EDTGEGeneral Electric April volatility elevated into Q1 and revenue outlook
Subscribe for More Information
April 15, 2014
10:18 EDTGEGE Healthcare completes acquisition of CHCA Computer Systems
Subscribe for More Information
10:01 EDTGEGeneral Electric says Dan Janki to lead GE's Treasury operations
GE Chairman and CEO Jeff Immelt announced the appointment of Dan Janki to lead GEís Treasury operations, succeeding Kathy Cassidy, who is retiring later this year after 35 years of service to GE. Mark Begor, who currently leads GE Capitalís Real Estate business, will succeed Janki as president & CEO of GE Energy Management. Alec Burger, currently the North America leader for GE Capital Real Estate, will succeed Mark Begor as president & CEO of GE Capital Real Estate. The CEO appointments are effective immediately and the formal Treasury transition will be effective by the end of April.
09:23 EDTSYKBarclays medical supplies/devices analysts hold analyst/industry conference call
Subscribe for More Information
07:09 EDTSYKStryker completes acquisition of Berchtold Holding AG
Subscribe for More Information
06:32 EDTAETPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:04 EDTGEGE CEO may give up leadership earlier than 20-year tenure, WSJ says
Subscribe for More Information
April 14, 2014
16:24 EDTMDTOn The Fly: Closing Wrap
Subscribe for More Information
12:26 EDTMDTOn The Fly: Midday Wrap
Subscribe for More Information
11:54 EDTGEGE reports Omnyx gets FDA clearance for digital manual read of HER2 slides
Subscribe for More Information
10:51 EDTMDTEdwards up after court limits sale of Medtronic's CoreValve in U.S.
Subscribe for More Information
10:02 EDTMDTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:02 EDTSYKOn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
09:00 EDTMDTMedtronic falls 5.4%
Medtronic is down 5.4%, or $3.20, to $56.00
08:59 EDTMDTOn The Fly: Pre-market Movers
Subscribe for More Information
07:39 EDTMDTEdwards Lifesciences upgraded to Buy from Fair Value at CRT Capital
Subscribe for More Information
07:28 EDTSYKStryker upgraded to Neutral from Reduce at SunTrust
Subscribe for More Information
06:22 EDTMDTMedtronic downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
06:21 EDTMDTEdwards Lifesciences upgraded to Neutral from Underweight at JPMorgan
Subscribe for More Information
April 13, 2014
15:10 EDTMDTMedtronic says CoreValve ruling has no impact outside U.S.
Subscribe for More Information
April 12, 2014
19:50 EDTMDTEdwards says court limits sale of Medtronic CoreValve system in U.S.
Edwards Lifesciences (EW) announced that the U.S. District Court for the District of Delaware granted a preliminary injunction limiting the sale of Medtronic's (MDT) CoreValve system in the United States. The court ordered the injunction to go into effect in seven business days. The hearing related to a federal jury decision in 2010 that CoreValve willfully infringes Edwards' U.S. Andersen transcatheter aortic valve replacement patent. At the conclusion of the hearing, Chief Judge Gregory Sleet ordered Edwards and Medtronic to confer on what instances the CoreValve device could continue to be used in the treatment of U.S. patients at centers currently trained on CoreValve. There is a large body of evidence demonstrating the safety and performance of the Edwards SAPIEN valves, and the company remains committed to ensuring patients have appropriate access to transcatheter therapy. This case was initiated by Edwards in 2008. On April 1, 2010, a federal jury found Medtronic willfully infringed Edwards' U.S. Andersen patent and awarded damages. In Nov. 2012, the U.S. Court of Appeals for the Federal Circuit affirmed the jury decision; in Oct. 2013, the U.S. Supreme Court declined to hear Medtronic's appeal. The patent involved in this suit is part of the Andersen family of patents. The U.S. Andersen patent was issued in 1995. A petition has been filed with the U.S. Patent and Trademark Office to extend this patent into early 2016. In a separate case, a federal jury in January found that Medtronic CoreValve had willfully infringed Edwards' U.S. Cribier transcatheter heart valve patent, and awarded damages to Edwards in that trial.
April 11, 2014
10:05 EDTAETAetna, Tenet form accountable care collaboration in San Antonio
Aetna (AET), Tenetís (THC) Baptist Health System and HealthTexas Medical Group announced an accountable care collaboration and the introduction of the Aetna Whole Health product in the San Antonio area. The health plans, designed for fully insured customers with employees who live or work in Bexar, Guadalupe, Comal and Kendall counties, will be available on July 1.
April 10, 2014
19:10 EDTMDTMedtronic confirms FDA approval for expanded indications
Subscribe for More Information
16:32 EDTMDTMedtronic gets FDA approval for revised labeling application
The U.S. FDA approved an application from Medtronic for revised labeling for two cardiac resynchronization pacemakers and eight cardiac resynchronization defibrillators, expanding the indication for use to patients with atrioventricular block and less severe heart failure. The FDA previously approved these devices for patients with more severe heart failure as evaluated by their physician using specific criteria. The new approved use includes patients with less severe heart failure, but who are already indicated to receive RV pacing. With the new indication, these patients will be eligible to receive a device that will pace both sides of their heart instead of just the right. Reference Link
09:03 EDTGEGE to provide grid modernization solutions to Furnas
GEís Digital Energy business is providing Furnas and Triangulo Mineiro Transmissora/Geoenergia with the latest in protection and control equipment to ensure performance and quality for each of the utilityís grid modernization projects. Furnas is one of the biggest utilities in Latin America and is responsible for power transmission in south, southeast and mid west Brazil. These projects, which support the modernization of Brazilís grid, mark GEís entry into Brazilís ANEEL transmission auctions. The auctions were won in December 2013 by TMT, a collaborative utility composed of Furnas and FIP Milao, with Furnas being the largest participant at 49%.
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use